Your browser doesn't support javascript.
loading
Secretion of cholesteryl ester transfer protein-lipoprotein complexes by human HepG2 hepatocytes.
Faust, R A; Cheung, M C; Albers, J J.
Affiliation
  • Faust RA; Department of Pathology, University of Washington School of Medicine, Seattle 98104-2499.
Atherosclerosis ; 77(1): 77-82, 1989 May.
Article in En | MEDLINE | ID: mdl-2497752
ABSTRACT
We have employed immunoaffinity chromatography to characterize the distribution of cholesteryl ester transfer activity in particles secreted by HepG2 hepatocytes. HepG2-secreted cholesteryl ester transfer activity is associated with apoprotein (apo) A-I (58%) as well as apo A-II (55%), and is not associated with apo B or E. In contrast, our previous studies have shown that most (88%) cholesteryl ester transfer activity in human plasma is associated with apo A-I whereas very little (7%) is associated with apo A-II. Thus, the distribution of cholesteryl ester transfer activity in plasma particles likely reflects active remodeling of nascent particles in the plasma compartment. Further data suggested that HepG2 cells secrete a lipid transfer inhibitor activity which is associated with apo E-containing lipoprotein particles. This inhibitory activity is heat labile.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Apolipoproteins / Glycoproteins / Carrier Proteins Limits: Humans Language: En Journal: Atherosclerosis Year: 1989 Type: Article
Search on Google
Database: MEDLINE Main subject: Apolipoproteins / Glycoproteins / Carrier Proteins Limits: Humans Language: En Journal: Atherosclerosis Year: 1989 Type: Article